Analysis of COVID-19 mortality in patients with comorbidities in Côte d'Ivoire.
Analysis of COVID-19 mortality in patients with comorbidities in Côte d'Ivoire.
复制标题
DOI：
10.4081/jphia.2022.1748
复制
发表时间：
2022-09-07
影响因子：
0.8
通讯作者：
Watabe S
中科院分区：
文献类型：
--
作者：
Usui R;Kanamori S;Aomori M;Watabe S
虽然COVID-19已在Côte科特迪瓦蔓延，但没有报告总结了COVID-19死亡病例的合并症。验证与Côte科特迪瓦普通成年人口相比，与记录的COVID-19死亡相关的商品类型和流行程度。有关COVID-19死亡的合并症和该国疾病结构的数据收集自政府官方报告和世卫组织的报告。在研究的67例患者中，年龄最大的是60-69岁，有23例（34%）。54名患者（81%）有非传染性疾病（NCDs）作为合并症。新冠肺炎死亡与普通成年人的患病率比：糖尿病为8.96[95%可信区间：6.86 ~ 11.68]，高血压为1.74[1.27 ~ 2.37]，肥胖为2.16[1.32 ~ 3.51]。为降低Côte科特迪瓦COVID-19的死亡风险，需要针对老年人和糖尿病患者采取重点感染预防措施。
Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire. Data on the comorbidities of COVID-19 deaths and the country’s disease structure were collected from official government reports and WHO’s reports. Among 67 patients studied, the biggest age group was 60-69 years old with 23 people (34%). Fifty-four patients (81%) had non-communicable diseases (NCDs) as comorbidities. The prevalence ratio between COVID-19 deaths and general adult population was 8.96 [95% Confidence Interval: 6.86-11.68] for diabetes, 1.74 [1.27-2.37] for hypertension, and 2.16 [1.32-3.51] for obesity. To reduce the risk of death from COVID-19 in Côte d’Ivoire, focused infection prevention measures for elderly and diabetic patients are needed.